| RS1554394506 |
AKR1D1
|
Health Risk |
Likely pathogenic |
— |
| RS1554395323 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1554395370 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS1554395411 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1554395431 |
COL1A2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Osteogenesis imperfecta type I |
| RS1554395470 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1554395471 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1554395656 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS1554395833 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Osteogenesis imperfecta |
| RS1554395903 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS1554395970 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS1554396083 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1554396162 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS1554396271 |
COL1A2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Ehlers-Danlos syndrome |
| RS1554396283 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type III |
| RS1554396355 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS1554396361 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1554396384 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1554396393 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1554396612 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1554396615 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1554396679 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1554396680 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1554396832 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1554396895 |
DLD
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554396908 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554396917 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1554396983 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1554397133 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type III |
| RS1554397197 |
FLNC
|
Health Risk |
Pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Hypertrophic cardiomyopathy 26 |
| RS1554397275 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1554397369 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS1554397464 |
FLNC
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 26, Distal myopathy with posterior leg and anterior hand involvement |
| RS1554397497 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1554397506 |
FLNC
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 26, Distal myopathy with posterior leg and anterior hand involvement |
| RS1554397515 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1554397527 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1554397593 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1554397621 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1554397750 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1554397769 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1554397772 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS1554397774 |
KCTD7
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Progressive myoclonic epilepsy type 3 |
| RS1554397834 |
KCTD7
|
Health Risk |
Likely pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS1554397852 |
RELN
|
Health Risk |
Pathogenic |
— |
| RS1554397975 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1554398092 |
FLNC
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 26, Distal myopathy with posterior leg and anterior hand involvement |
| RS1554398094 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS1554398126 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS1554398193 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554398251 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1554398261 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1554398264 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554398361 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS1554398396 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Ehlers-Danlos syndrome |
| RS1554398461 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554398510 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1554398624 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554398625 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554398674 |
FLNC
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS1554398705 |
FLNC
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS1554398835 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1554399014 |
FLNC
|
Health Risk |
Pathogenic |
Dilated Cardiomyopathy, Dominant |
| RS1554399513 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 26 |
| RS1554399572 |
AGK
|
Health Risk |
Pathogenic |
Sengers syndrome, Sengers syndrome |
| RS1554400021 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 26, Distal myopathy with posterior leg and anterior hand involvement |
| RS1554400179 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554400242 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Hypertrophic cardiomyopathy 26 |
| RS1554400286 |
MET
|
Health Risk |
Pathogenic; risk factor |
Arthrogryposis, distal |
| RS1554400338 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS1554400483 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554400699 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554400700 |
FLNC
|
Health Risk |
Pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Hypertrophic cardiomyopathy 26 |
| RS1554400703 |
FLNC
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 26, Myofibrillar myopathy 5 |
| RS1554400704 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554400713 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554400720 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1554400962 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Restrictive cardiomyopathy, Cardiovascular phenotype |
| RS1554401324 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1554401344 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1554401403 |
FLNC-AS1;FLNC
|
Health Risk |
Likely pathogenic |
Restrictive cardiomyopathy, Restrictive cardiomyopathy |
| RS1554401434 |
AUTS2
|
Health Risk |
Pathogenic |
Autism spectrum disorder due to AUTS2 deficiency, Autism spectrum disorder due to AUTS2 deficiency |
| RS1554401561 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Distal myopathy with posterior leg and anterior hand involvement |
| RS1554401581 |
FLNC
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 26, Distal myopathy with posterior leg and anterior hand involvement |
| RS1554401640 |
AGK
|
Health Risk |
Pathogenic |
Sengers syndrome, Sengers syndrome |
| RS1554401641 |
AGK
|
Health Risk |
Pathogenic |
Sengers syndrome, Sengers syndrome |
| RS1554401756 |
FLNC
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 26, Distal myopathy with posterior leg and anterior hand involvement |
| RS1554401780 |
FLNC
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 26 |
| RS1554401811 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 3, Progressive familial intrahepatic cholestasis type 3 |
| RS1554401830 |
FLNC
|
Health Risk |
Pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Hypertrophic cardiomyopathy 26 |
| RS1554401837 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS1554402003 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS1554402015 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal myopathy with posterior leg and anterior hand involvement, Hypertrophic cardiomyopathy 26 |
| RS1554402092 |
CAMK2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 54 |
| RS1554403310 |
BRAF
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS1554403626 |
TSPAN12
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS1554403767 |
TSPAN12
|
Health Risk |
Pathogenic |
Vitreoretinopathy, Vitreoretinopathy |
| RS1554404013 |
RELN
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554404337 |
RELN
|
Health Risk |
Likely pathogenic |
— |
| RS1554404338 |
RELN
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |